Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
Liu Z, Zhu J, Cao H, Ren H, Fang X.
Int J Oncol. 2012 May;40(5):1553-60. doi: 10.3892/ijo.2012.1342. Epub 2012 Jan 24.
Related citations
Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H, Kim JH, Lee YS, Lee YC.
Int J Oncol. 2012 May;40(5):1533-42. doi: 10.3892/ijo.2012.1327. Epub 2012 Jan 10.
Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning.
Shibata-Minoshima F, Oki T, Doki N, Nakahara F, Kageyama S, Kitaura J, Fukuoka J, Kitamura T.
Int J Oncol. 2012 Jan;40(1):93-8. doi: 10.3892/ijo.2011.1173. Epub 2011 Aug 19.
NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations.
Park E, Park J, Han SW, Im SA, Kim TY, Oh DY, Bang YJ.
Int J Oncol. 2012 Apr;40(4):1259-66. doi: 10.3892/ijo.2011.1290. Epub 2011 Dec 8.
Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use.
Kim KY, Yi BR, Lee HR, Kang NH, Jeung EB, Kim SU, Choi KC.
Int J Oncol. 2012 Apr;40(4):1097-104. doi: 10.3892/ijo.2011.1288. Epub 2011 Dec 8.
Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells.
Fukuda K, Saikawa Y, Takahashi M, Takahashi T, Wada N, Kawakubo H, Takeuchi H, Kitagawa Y.
Int J Oncol. 2012 Apr;40(4):975-82. doi: 10.3892/ijo.2011.1279. Epub 2011 Dec 1.
Novel anti-cancer role of naphthazarin in human gastric cancer cells.
Kim JA, Lee EK, Park SJ, Kim ND, Hyun DH, Lee CG, Lee JH, Yang KM, Heo K, Son TG.
Int J Oncol. 2012 Jan;40(1):157-62. doi: 10.3892/ijo.2011.1195. Epub 2011 Sep 8.
SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancer.
Schimanski CC, Jordan M, Schlaegel F, Schmidtmann I, Lang H, Galle PR, Moehler M, Gockel I.
Int J Oncol. 2011 Aug;39(2):515-20. doi: 10.3892/ijo.2011.1044. Epub 2011 May 16.
Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.
Nakata W, Hayakawa Y, Nakagawa H, Sakamoto K, Kinoshita H, Takahashi R, Hirata Y, Maeda S, Koike K.
Int J Oncol. 2011 Dec;39(6):1529-36. doi: 10.3892/ijo.2011.1141. Epub 2011 Jul 22.
Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
Tanaka F, Matsuzaki S, Mimori K, Kita Y, Inoue H, Mori M.
Int J Oncol. 2011 Aug;39(2):361-72. doi: 10.3892/ijo.2011.1056. Epub 2011 May 25.
Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
Ii M, Yamamoto H, Taniguchi H, Adachi Y, Nakazawa M, Ohashi H, Tanuma T, Sukawa Y, Suzuki H, Sasaki S, Imai K, Shinomura Y.
Int J Oncol. 2011 Sep;39(3):593-9. doi: 10.3892/ijo.2011.1048. Epub 2011 May 20.
Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma.
Kim MY, Han SI, Lim SC.
Int J Oncol. 2011 May;38(5):1375-83. doi: 10.3892/ijo.2011.948. Epub 2011 Feb 18.
Clinical significance of expression of Hint1 and potential epigenetic mechanism in gastric cancer.
Huang H, Wei X, Su X, Qiao F, Xu Z, Gu D, Fan H, Chen J.
Int J Oncol. 2011 Jun;38(6):1557-64. doi: 10.3892/ijo.2011.994. Epub 2011 Apr 4.
(-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression.
Onoda C, Kuribayashi K, Nirasawa S, Tsuji N, Tanaka M, Kobayashi D, Watanabe N.
Int J Oncol. 2011 May;38(5):1403-8. doi: 10.3892/ijo.2011.951. Epub 2011 Feb 22.
Feasibility of tailored, selective and effective anticancer chemotherapy by direct injection of docetaxel-loaded immunoliposomes into Her2/neu positive gastric tumor xenografts.
Yamamoto Y, Yoshida M, Sato M, Sato K, Kikuchi S, Sugishita H, Kuwabara J, Matsuno Y, Kojima Y, Morimoto M, Horiuchi A, Watanabe Y.
Int J Oncol. 2011 Jan;38(1):33-9.
Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
Bai Z, Ye Y, Liang B, Xu F, Zhang H, Zhang Y, Peng J, Shen D, Cui Z, Zhang Z, Wang S.
Int J Oncol. 2011 Feb;38(2):375-83. doi: 10.3892/ijo.2010.873. Epub 2010 Dec 15.
Apoptosis induction by glycoprotein isolated from Laminaria japonica is associated with down-regulation of telomerase activity and prostaglandin E2 synthesis in AGS human gastric cancer cells.
Han MH, Kim GY, Moon SK, Kim WJ, Nam TJ, Choi YH.
Int J Oncol. 2011 Feb;38(2):577-84. doi: 10.3892/ijo.2010.853. Epub 2010 Dec 3.
Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model.
Kawaguchi K, Etoh T, Suzuki K, Mitui MT, Nishizono A, Shiraishi N, Kitano S.
Int J Oncol. 2010 Dec;37(6):1433-8.
Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer.
Lo Nigro C, Monteverde M, Riba M, Lattanzio L, Tonissi F, Garrone O, Heouaine A, Gallo F, Ceppi M, Borghi F, Comino A, Merlano M.
Int J Oncol. 2010 Nov;37(5):1219-28.
A quantitative evaluation of the determinant proteins for S-1 responsiveness in a biopsy specimen assists in patient selection to neoadjuvant therapy in cases of advanced gastric cancer.
Hashiguchi K, Kitajima Y, Kai K, Hiraki M, Nakamura J, Tokunaga O, Noshiro H, Miyazaki K.
Int J Oncol. 2010 Aug;37(2):257-64.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on